Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. The company offers automatic detection instruments, including coagulation, hemorheology, hematocrit, and platelet aggregation, as well as supporting reagents and consumables. Its products are used in the prevention, screening, diagnosis, and monitoring of thrombophilia, coronary heart disease, venous thromboembolism, and other thrombotic and bleeding diseases. Beijing Succeeder Technology Inc. was founded in 2003 and is based in Beijing, China.

Sector

Healthcare

Industry

Medical - Devices

CEO

Wang, Hai

Employees

278

Website

www.succeeder.com.cn

IPO Date

2020-08-06

Headquarters

Building 1, Yard 7, Floor 8, Science Park Road, Changping District, Beijing 102206, China

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.